HUM Humana Inc. Common Stock

NYSE · Health Care · Visualizza su SEC EDGAR ↗
$382,25
Prezzo · Ago 19, 2026
Fondamentali al Lug 29, 2026

Informazioni su Humana Inc. Common Stock Panoramica della società da Wikipedia

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

Leggi di più

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.

In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.

On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.

In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.

In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."

In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.

In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.

In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.

In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.

Corporate affairs

Sponsorship

Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.

Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.

Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.

The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.

In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.

On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

HUM Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$382.25
Capitalizzazione di Mercato
$75.96B
P/E (TTM)
38.8
EPS (TTM)
$9.84
Ricavi (TTM)
$129.66B
Rendimento div.
0.56%
ROE
7.0%
D/E Debito/Patrimonio
0.7
Intervallo 52 sett.
$163 – $429

HUM Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $129.66B
10-point trend, +138.4%
2016-12-31 2025-12-31
EPS $9.84
10-point trend, +141.8%
2016-12-31 2025-12-31
Flusso di cassa libero $375M
10-point trend, -73.4%
2016-12-31 2025-12-31
Margini 0.92%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
HUM
Mediana dei peer
P/E (TTM)
5-point trend, +27.2%
38.8
36.8
P/S (TTM)
4-point trend, -64.2%
0.6
0.8
P/B
4-point trend, -56.6%
4.3
3.4
EV / EBITDA
4-point trend, -33.7%
25.3
Price / FCF (Prezzo / FCF)
4-point trend, +362.5%
202.6

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
HUM
Mediana dei peer
Operating Margin (Margine Operativo)
5-point trend, -44.9%
2.1%
Net Profit Margin (Margine di Profitto Netto)
5-point trend, -73.9%
0.92%
0.85%
ROA
5-point trend, -66.3%
2.5%
2.8%
ROE
5-point trend, -61.5%
7.0%
8.2%
ROIC
5-point trend, -26.6%
7.4%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
HUM
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
5-point trend, +7.0%
0.7
Current Ratio (Rapporto corrente)
5-point trend, +23.3%
2.0
1.5
Quick Ratio
5-point trend, +18.1%
1.4

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
HUM
Mediana dei peer
Revenue YoY (Ricavi YoY)
5-point trend, +56.1%
10.1%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
5-point trend, +56.1%
11.8%
Revenue CAGR 5Y (CAGR Ricavi 5Y)
5-point trend, +56.1%
10.9%
EPS YoY
5-point trend, -56.6%
-1.4%
Net Income YoY (Utile Netto YoY)
5-point trend, -59.5%
-1.6%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
HUM
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
5-point trend, -56.6%
$9.84

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
HUM
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
5-point trend, +199.9%
36.2%

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

Dividend Yield
0.56%
Rapporto di Distribuzione Utili
36.2%
CAGR Dividendi 5Y
Data ex-dividendoImporto
26 Giugno 2026$0,8850
27 Marzo 2026$0,8850
26 Dicembre 2025$0,8850
26 Settembre 2025$0,8850
27 Giugno 2025$0,8850
28 Marzo 2025$0,8850
31 Dicembre 2024$0,8850
30 Settembre 2024$0,8850
28 Giugno 2024$0,8850
27 Marzo 2024$0,8850
28 Dicembre 2023$0,8850
28 Settembre 2023$0,8850
29 Giugno 2023$0,8850
30 Marzo 2023$0,8850
29 Dicembre 2022$0,7880
29 Settembre 2022$0,7880
29 Giugno 2022$0,7880
30 Marzo 2022$0,7880
30 Dicembre 2021$0,7000
29 Settembre 2021$0,7000

HUM Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 33 analisti
  • Acquisto forte 8 24,2%
  • Compra 8 24,2%
  • Mantieni 15 45,5%
  • Vendi 2 6,1%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

23 analisti · 2026-08-19
Target mediano $415.00 +8,6%
Target medio $416.43 +8,9%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.42%
Periodo EPS Actual EPS Stimato Sorpresa
30 Giugno 2026 $7.61 $7.29 0.32%
31 Marzo 2026 $10.31 $10.29 0.02%
31 Dicembre 2025 $-3.96 $-4.05 0.09%
30 Settembre 2025 $3.24 $2.85 0.39%
30 Giugno 2025 $6.27 $5.98 0.29%
31 Marzo 2025 $11.58 $10.17 1.4%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
HUM $50.90B 26.0 10.1% 0.92% 7.0%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
ELV $77.37B 13.9 12.5% 2.8% 13.3%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 13
Dati annuali Conto Economico per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
SG&A Expense 12-point trend, +102.3% $15.45B $13.70B $13.19B $12.67B $10.12B $10.05B $7.38B $7.53B $6.57B $7.17B $7.29B $7.64B
Operating Income 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Interest Expense 10-point trend, +156.8% · · $493M $401M $326M $283M $242M $218M $242M $189M $186M $192M
Other Non-op 10-point trend, -451000000.00 $-451M $-181M $-137M $-68M $532M $-103M $506M $-33M $0 $0 · ·
Pretax Income 12-point trend, -33.7% $1.44B $1.62B $3.33B $3.57B $3.42B $4.67B $3.47B $2.07B $4.02B $1.55B $2.43B $2.17B
Income Tax 12-point trend, -75.6% $250M $413M $836M $762M $485M $1.31B $763M $391M $1.57B $938M $1.16B $1.02B
Net Income 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
EPS (Basic) 12-point trend, +32.7% $9.87 $10.01 $20.09 $22.20 $22.79 $25.47 $20.20 $12.24 $16.94 $4.11 $8.54 $7.44
EPS (Diluted) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Shares (Basic) 12-point trend, -21.9% 120,454,000 120,571,000 123,866,000 126,419,000 128,688,000 132,199,000 134,055,000 137,486,000 144,493,000 149,375,000 149,455,000 154,187,000
Shares (Diluted) 12-point trend, -22.5% 120,826,000 120,869,000 124,441,000 127,094,000 129,396,000 133,012,000 134,727,000 138,403,000 145,585,000 150,917,000 151,142,000 155,874,000
EBITDA 12-point trend, +14.5% $2.70B $2.56B $4.01B $3.80B $3.15B $4.99B $3.19B $3.10B $4.26B $1.74B $2.35B $2.36B
Stato Patrimoniale 26
Dati annuali Stato Patrimoniale per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +117.1% $4.20B $2.22B $4.69B $5.06B $3.39B $4.67B $4.05B $2.34B $4.04B $3.88B $2.57B $1.94B
Short-term Investments 7-point trend, +43.1% $15.70B $18.21B $16.63B $13.88B $13.19B $12.55B $10.97B · · · · ·
Receivables 12-point trend, +210.5% $3.27B $2.70B $2.04B $1.67B $1.81B $1.14B $1.06B $1.01B $854M $1.28B $1.16B $1.05B
Other Current Assets 12-point trend, +138.6% $9.56B $6.68B $6.63B $5.57B $6.49B $5.28B $3.81B $3.56B $2.95B $3.44B $4.71B $4.01B
Current Assets 12-point trend, +110.7% $32.73B $29.82B $29.99B $26.18B $24.89B $23.64B $19.89B $16.95B $17.40B $16.19B $15.71B $15.54B
PP&E (Net) 12-point trend, +81.7% $2.23B $2.53B $3.03B $3.22B $3.07B $2.37B $1.96B $1.74B $1.58B $1.50B $1.38B $1.23B
PP&E (Gross) 12-point trend, +89.9% $5.52B $5.67B $5.88B $6.36B $5.95B $5.49B $4.62B $4.05B $3.56B $3.19B $2.72B $2.91B
Accum. Depreciation 12-point trend, +95.8% $3.29B $3.14B $2.85B $3.14B $2.87B $3.12B $2.66B $2.31B $1.98B $1.69B $1.34B $1.68B
Goodwill 12-point trend, +199.8% $9.69B $9.63B $9.55B $9.14B $11.09B $4.45B $3.93B $3.90B $3.28B $3.27B $3.27B $3.23B
Intangibles 12-point trend, +156.4% $1.13B $1.44B $1.69B $1.76B $2.64B $329M $177M $245M $226M $280M $357M $440M
Other Non-current Assets 12-point trend, +97.6% $3.13B $3.38B $3.38B $3.38B $4.38B $2.13B $1.83B $1.38B $2.17B $2.23B $2.48B $1.58B
Total Assets 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Accounts Payable 12-point trend, +172.9% $5.72B $5.26B $6.57B $5.24B $4.51B $4.01B $3.75B $3.07B $4.07B $2.47B $2.21B $2.10B
Short-term Debt 5-point trend, +1694000000.00 · · · · · · · $1.69B $150M $300M $299M $0
Current Liabilities 12-point trend, +118.8% $16.35B $16.94B $18.87B $17.18B $15.33B $13.39B $10.93B $10.08B $9.41B $7.82B $8.15B $7.47B
Capital Leases 7-point trend, +25.9% $418M $392M $444M $456M $546M $355M $332M · · · · ·
Other Non-current Liabilities 12-point trend, +941.1% $2.46B $1.95B $1.66B $1.47B $2.38B $1.79B $1.14B $581M $237M $263M $235M $236M
Total Liabilities 12-point trend, +124.6% $31.17B $30.03B $30.75B $27.68B $28.25B $21.24B $17.04B $15.25B $17.34B $14.71B $14.33B $13.88B
Total Debt 12-point trend, +223.4% $12.37B $11.14B $10.21B $9.03B $10.54B $6.06B $4.97B $6.07B $4.92B $4.09B $4.12B $3.83B
Common Stock Flat — no change across 12 periods $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M $33M
Retained Earnings 12-point trend, +193.2% $29.07B $28.32B $27.54B $25.49B $23.09B $20.52B $17.48B $15.07B $13.67B $11.45B $11.02B $9.92B
Treasury Stock 12-point trend, +404.8% $14.42B $14.37B $13.66B $12.16B $10.16B $9.92B $8.46B $7.32B $6.33B $3.30B $3.29B $2.86B
AOCI 12-point trend, -383.9% $-633M $-1.07B $-999M $-1.30B $42M $391M $156M $-159M $19M $-66M $58M $223M
Stockholders' Equity 12-point trend, +83.0% $17.66B $16.38B $16.26B $15.31B $16.08B $13.73B $12.04B $10.16B $9.84B $10.69B $10.35B $9.65B
Liabilities + Equity 12-point trend, +107.9% $48.91B $46.48B $47.06B $43.05B $44.36B $34.97B $29.07B $25.41B $27.18B $25.40B $24.68B $23.53B
Shares Outstanding 7-point trend, +0.0% 198,719,000 198,719,000 198,690,000 198,667,000 198,649,000 198,649,000 198,630,000 · · · · ·
Flusso di cassa 17
Dati annuali Flusso di cassa per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
D&A 10-point trend, +112.8% $698M $839M $779M $709M $596M · · $444M $410M $388M $354M $328M
Stock-based Comp 12-point trend, +145.9% $241M $207M $175M $216M $180M $181M $163M $137M $157M $115M $109M $98M
Deferred Tax 12-point trend, +217.2% $75M $-192M $-164M $-100M $15M $195M $162M $194M $132M $-71M $-2M $-64M
Amort. of Intangibles 12-point trend, -57.9% $51M $60M $67M $81M $65M $88M $70M $90M $75M $77M $93M $121M
Restructuring 2-point trend, -68.2% · · · · · · $47M · $148M · · ·
Operating Cash Flow 12-point trend, -43.1% $921M $2.97B $3.98B $4.59B $2.26B $5.64B $5.28B $2.17B $4.05B $1.94B $868M $1.62B
CapEx 12-point trend, +3.4% $546M $575M $1.00B $1.14B $1.34B $964M $736M $612M $524M $527M $523M $528M
Investing Cash Flow 12-point trend, +3707.9% $2.27B $-2.95B $-3.49B $-1.01B $-6.56B $-3.06B $-1.28B $-3.09B $-2.94B $-1.36B $320M $-63M
Net Debt Issued 6-point trend, +20.0% · · · · · · $-400M $0 $-800M $0 $0 $-500M
Stock Repurchased 12-point trend, -82.7% $151M $817M $1.57B $2.10B $79M $1.82B $1.07B $1.09B $3.37B $104M $385M $872M
Net Stock Activity 12-point trend, +82.7% $-151M $-817M $-1.57B $-2.10B $-79M $-1.82B $-1.07B $-1.09B $-3.37B $-104M $-385M $-872M
Dividends Paid 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M
Financing Cash Flow 12-point trend, -60.3% $-1.22B $-2.49B $-856M $-1.91B $3.02B $-1.96B $-2.29B $-785M $-945M $732M $-552M $-758M
Net Change in Cash 12-point trend, +148.3% $1.98B $-2.47B $-367M $1.67B $-1.28B $619M $1.71B $-1.70B $165M $1.31B $636M $797M
Taxes Paid 11-point trend, -44.7% · $570M $997M $758M $227M $1.13B $518M $631M $1.50B $916M $1.18B $1.03B
Free Cash Flow 12-point trend, -65.6% $375M $2.39B $2.98B $3.47B $946M $4.67B $4.55B $1.56B $3.52B $1.41B $345M $1.09B
Levered FCF 10-point trend, +163.8% · · $2.61B $3.15B $666M $4.47B $4.36B $1.38B $3.38B $1.33B $247M $989M
Redditività 7
Dati annuali Redditività per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
Net Margin 12-point trend, -61.0% 0.92% 1.0% 2.3% 3.0% 3.5% 4.4% 4.2% 3.0% 4.5% 1.1% 2.4% 2.4%
Pretax Margin 12-point trend, -75.2% 1.1% 1.5% 3.1% 3.8% 4.1% 6.1% 5.3% 3.6% 7.5% 2.9% 4.5% 4.5%
EBITDA Margin 12-point trend, -57.1% 2.1% 2.2% 3.8% 4.1% 3.8% 6.5% 4.9% 5.5% 7.9% 3.2% 4.3% 4.9%
ROA 12-point trend, -52.0% 2.5% 2.6% 5.5% 6.4% 7.4% 10.5% 9.9% 6.4% 9.3% 2.5% 5.3% 5.2%
ROE 12-point trend, -42.3% 7.0% 7.4% 15.8% 18.2% 18.1% 22.8% 22.9% 16.2% 23.3% 5.8% 12.8% 12.1%
ROIC 12-point trend, -19.7% 7.4% 7.1% 11.3% 12.3% 10.1% 18.1% 14.6% 15.5% 17.6% 4.7% 8.5% 9.3%
Liquidità e Solvibilità 5
Dati annuali Liquidità e Solvibilità per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, +0.1% 2.0 1.8 1.6 1.5 1.6 1.8 1.8 1.7 1.9 2.1 1.9 2.0
Quick Ratio 12-point trend, +236.0% 1.4 1.4 1.2 1.2 1.2 1.4 0.5 0.3 0.5 0.7 0.5 0.4
Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.6 0.5 0.4 0.4 0.4
LT Debt / Equity 12-point trend, +76.7% 0.7 0.7 0.6 0.6 0.7 0.4 0.4 0.4 0.5 0.4 0.4 0.4
Interest Coverage 10-point trend, -33.8% · · 8.1 9.5 9.7 17.6 13.2 14.2 17.6 9.2 12.6 12.3
Efficienza 2
Dati annuali Efficienza per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +23.9% 2.7 2.5 2.4 2.1 2.1 2.4 2.4 2.2 2.0 2.2 2.3 2.2
Receivables Turnover 12-point trend, -5.2% 43.4 49.7 57.4 53.3 56.3 70.3 62.7 60.9 50.4 44.6 49.0 45.8
Per Azione 7
Dati annuali Per Azione per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Book Value / Share 4-point trend, +15.3% $88.85 $82.40 $81.85 $77.07 · · · · · · · ·
Revenue / Share 12-point trend, +244.9% $1073.15 $974.29 $854.81 $730.72 $641.94 $580.06 $481.63 $411.20 $369.32 $360.32 $359.19 $311.15
Cash Flow / Share 12-point trend, -26.6% $7.62 $24.54 $31.99 $36.09 $17.48 $42.39 $39.22 $15.70 $27.83 $12.83 $5.74 $10.38
Cash / Share 4-point trend, -17.0% $21.14 $11.18 $23.62 $25.47 · · · · · · · ·
Dividend / Share 3-point trend, +4.5% · · · · · · · · · $1 $1 $1
Dividend Paid / Share 12-point trend, +221.8% $4 $4 $3 $3 $3 $2 $2 $2 $1 $1 $1 $1
EPS (TTM) 12-point trend, +33.7% $9.84 $9.98 $20.00 $22.08 $22.67 $25.31 $20.10 $12.16 $16.81 $4.07 $8.44 $7.36
Tassi di Crescita 10
Dati annuali Tassi di Crescita per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +32.0% 10.1% 10.7% 14.5% 11.8% 7.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +4.2% 11.8% 12.3% 11.3% · · · · · · · · ·
Revenue CAGR 5Y 10.9% · · · · · · · · · · ·
EPS YoY 5-point trend, +86.6% -1.4% -50.1% -9.4% -2.6% -10.4% · · · · · · ·
EPS CAGR 3Y 3-point trend, -212.8% -23.6% -23.9% -7.5% · · · · · · · · ·
EPS CAGR 5Y -17.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +87.8% -1.6% -51.5% -11.3% -4.3% -12.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -160.0% -24.9% -25.6% -9.6% · · · · · · · · ·
Net Income CAGR 5Y -18.8% · · · · · · · · · · ·
Dividend CAGR 5Y 5.9% · · · · · · · · · · ·
Valutazione (TTM) 17
Dati annuali Valutazione (TTM) per HUM
Metrica Tendenza 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +167.3% $129.66B $117.76B $106.37B $92.87B $83.06B $77.16B $64.89B $56.91B $53.77B $54.38B $54.29B $48.50B
Net Income TTM 12-point trend, +3.6% $1.19B $1.21B $2.49B $2.81B $2.93B $3.37B $2.71B $1.68B $2.45B $614M $1.28B $1.15B
Market Cap 4-point trend, -50.0% $50.90B $50.42B $90.96B $101.76B · · · · · · · ·
Enterprise Value 4-point trend, -52.8% $43.36B $41.13B $79.86B $91.85B · · · · · · · ·
P/E 12-point trend, +33.4% 26.0 25.4 22.9 23.2 20.5 16.2 18.2 23.6 14.8 50.1 21.2 19.5
P/S 4-point trend, -64.2% 0.4 0.4 0.9 1.1 · · · · · · · ·
P/B 4-point trend, -56.6% 2.9 3.1 5.6 6.6 · · · · · · · ·
P / Tangible Book 4-point trend, -67.8% 7.4 9.5 18.1 23.1 · · · · · · · ·
P / Cash Flow 4-point trend, +149.1% 55.3 17.0 22.8 22.2 · · · · · · · ·
P / FCF 4-point trend, +362.5% 135.7 21.1 30.6 29.3 · · · · · · · ·
EV / EBITDA 4-point trend, -33.7% 16.0 16.1 19.9 24.2 · · · · · · · ·
EV / FCF 4-point trend, +336.5% 115.6 17.2 26.8 26.5 · · · · · · · ·
EV / Revenue 4-point trend, -66.2% 0.3 0.3 0.8 1.0 · · · · · · · ·
Dividend Yield 4-point trend, +115.4% 0.84% 0.85% 0.47% 0.39% · · · · · · · ·
Earnings Yield 12-point trend, -25.0% 3.8% 3.9% 4.4% 4.3% 4.9% 6.2% 5.5% 4.2% 6.8% 2.0% 4.7% 5.1%
Payout Ratio 12-point trend, +141.3% 36.2% 35.7% 17.3% 14.0% 12.1% 9.6% 10.8% 15.8% 9.0% 28.8% 13.5% 15.0%
Annual Payout 12-point trend, +150.0% $430M $431M $431M $392M $354M $323M $291M $265M $220M $177M $172M $172M

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ricavi $129.66B$117.76B$106.37B$92.87B$83.06B
Margine Operativo % 2.1%2.2%3.8%4.1%3.8%
Utile netto $1.19B$1.21B$2.49B$2.81B$2.93B
EPS Diluito $9.84$9.98$20.00$22.08$22.67
Stato Patrimoniale
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debito / Patrimonio Netto 0.70.70.60.60.7
Rapporto corrente 2.01.81.61.51.6
Quick Ratio 1.41.41.21.21.2
Flusso di cassa
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flusso di cassa libero $375M$2.39B$2.98B$3.47B$946M

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 1.050 filer · $33.7B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
255 (+136 vs trimestre precedente) 83 (-77 vs trimestre precedente) 316 (+44 vs trimestre precedente) 274 (-45 vs trimestre precedente) +8.8M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
Dodge & Cox $4.345.737.744 10.940.380 12,89% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $3.115.642.737 7.843.620 9,24% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $2.311.405.702 5.818.956 6,86% Azioni
STATE STREET CORP $2.172.441.313 5.457.072 6,45% Azioni
EAGLE CAPITAL MANAGEMENT LLC $1.528.010.749 3.846.762 4,53% Azioni
Sessa Capital IM, L.P. $1.480.732.883 3.727.740 4,39% Azioni
GEODE CAPITAL MANAGEMENT, LLC $1.181.074.714 2.976.242 3,50% Azioni
Capital International Investors $950.462.637 2.392.826 2,82% Azioni
NAYA CAPITAL MANAGEMENT UK LTD $728.407.339 1.833.763 2,16% Azioni
NORGES BANK $694.505.009 1.748.414 2,06% Azioni
GOLDMAN SACHS GROUP INC $659.096.868 1.659.274 1,96% Azioni
FMR LLC $615.633.048 1.549.854 1,83% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544.502.820 1.370.784 1,62% Azioni
Capital Research Global Investors $443.462.035 1.116.990 1,32% Azioni
Slate Path Capital LP $428.969.795 1.079.930 1,27% Azioni
Capital World Investors $406.119.738 1.022.425 1,21% Azioni
Newport Trust Company, LLC $384.768.345 968.653 1,14% Azioni
CITADEL ADVISORS LLC $363.376.856 914.800 1,08% Opzione Call
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348.908.912 878.377 1,04% Azioni
DIMENSIONAL FUND ADVISORS LP $331.490.508 834.526 0,98% Azioni
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314.921.577 792.814 0,93% Azioni
CITADEL ADVISORS LLC $310.904.094 782.700 0,92% Opzione Put
WELLINGTON MANAGEMENT GROUP LLP $282.117.958 710.231 0,84% Azioni
VANGUARD FIDUCIARY TRUST CO $267.791.027 674.163 0,79% Azioni
Maple Rock Capital Partners Inc. $249.553.862 628.251 0,74% Azioni
Diamond Hill Capital Management, LLC (Investment Advisor) $245.555.446 618.185 0,73% Azioni
GOLDMAN SACHS GROUP INC $232.333.978 584.900 0,69% Opzione Call
MARSHALL WACE, LLP $216.873.381 545.978 0,64% Azioni
CITADEL ADVISORS LLC $178.080.082 448.316 0,53% Azioni
High Ground Investment Management LLP $177.941.848 447.968 0,53% Azioni
1832 Asset Management L.P. $176.401.430 444.090 0,52% Azioni
BCV Asset Management Inc. $173.695.656 445.719 0,52% Azioni
BANK OF AMERICA CORP /DE/ $172.703.708 434.781 0,51% Azioni
Holocene Advisors, LP $165.040.541 415.489 0,49% Azioni
BNP PARIBAS FINANCIAL MARKETS $147.490.964 371.308 0,44% Azioni
MILLENNIUM MANAGEMENT LLC $140.098.700 352.698 0,42% Azioni
JANE STREET GROUP, LLC $137.080.622 345.100 0,41% Opzione Call
Swiss National Bank $134.522.525 338.660 0,40% Azioni
JANE STREET GROUP, LLC $122.542.370 308.500 0,36% Opzione Put
STEADFAST CAPITAL MANAGEMENT LP $122.423.204 308.200 0,36% Azioni
BlackRock, Inc. $120.890.332 304.341 0,36% Azioni
Mitsubishi UFJ Asset Management Co., Ltd. $115.565.201 290.935 0,34% Azioni
VANGUARD ASSET MANAGEMENT, Ltd $109.135.401 274.748 0,32% Azioni
AMERIPRISE FINANCIAL INC $108.302.217 272.614 0,32% Azioni
Legal & General Group Plc $103.424.967 260.372 0,31% Azioni
Vanguard Global Advisers, LLC $103.330.825 260.135 0,31% Azioni
GOLDMAN SACHS GROUP INC $103.078.590 259.500 0,31% Opzione Put
NEUBERGER BERMAN GROUP LLC $102.585.352 258.258 0,30% Azioni
BANK OF NOVA SCOTIA $102.313.941 257.575 0,30% Azioni
RHUMBLINE ADVISERS $102.294.748 257.527 0,30% Azioni
Sumitomo Mitsui Trust Group, Inc. $101.464.685 255.437 0,30% Azioni
GLENVIEW CAPITAL MANAGEMENT, LLC $100.979.680 254.216 0,30% Azioni
Gotham Asset Management, LLC $89.318.889 224.860 0,27% Azioni
Balyasny Asset Management L.P. $87.965.958 221.454 0,26% Azioni
FIRST TRUST ADVISORS LP $85.094.587 214.226 0,25% Azioni
Ensign Peak Advisors, Inc $83.532.585 210.293 0,25% Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C. $83.463.866 210.120 0,25% Azioni
Brandywine Global Investment Management, LLC $80.388.706 313.859 0,24% Azioni
California Public Employees Retirement System $80.274.587 202.091 0,24% Azioni
WOLVERINE TRADING, LLC $76.135.109 298.300 0,23% Opzione Call
Camber Capital Management LP $73.344.000 300.000 0,22% Azioni
National Pension Service $70.860.473 178.391 0,21% Azioni
BARCLAYS PLC $70.472.788 177.415 0,21% Azioni
Susquehanna Portfolio Strategies, LLC $69.949.250 176.097 0,21% Azioni
Walleye Trading LLC $69.473.778 174.900 0,21% Opzione Call
CANADA PENSION PLAN INVESTMENT BOARD $68.018.761 171.237 0,20% Azioni
ARGA Investment Management, LP $66.165.730 166.572 0,20% Azioni
ORBIMED ADVISORS LLC $65.183.802 164.100 0,19% Azioni
Solel Partners LP $64.742.888 162.990 0,19% Azioni
AMF Tjanstepension AB $61.961.951 155.989 0,18% Azioni
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $60.794.124 153.049 0,18% Azioni
Perpetual Ltd $57.945.659 145.878 0,17% Azioni
CI INVESTMENTS INC. $57.302.560 144.259 0,17% Azioni
AMERICAN CENTURY COMPANIES INC $56.575.256 142.426 0,17% Azioni
Squarepoint Ops LLC $56.047.742 141.100 0,17% Opzione Put
Aberdeen Group plc $53.345.852 134.298 0,16% Azioni
WOLVERINE TRADING, LLC $52.653.949 206.300 0,16% Opzione Put
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $52.178.000 131.358 0,15% Azioni
ING GROEP NV $51.583.784 129.862 0,15% Azioni
Squarepoint Ops LLC $50.685.272 127.600 0,15% Opzione Call
Walleye Trading LLC $49.573.056 124.800 0,15% Opzione Put
D. E. Shaw & Co., Inc. $46.514.462 117.100 0,14% Opzione Call
BRAIDWELL LP $45.481.690 114.500 0,13% Azioni
Jain Global LLC $43.694.200 110.000 0,13% Opzione Put
BANK OF MONTREAL /CAN/ $43.207.208 108.774 0,13% Azioni
Zurcher Kantonalbank (Zurich Cantonalbank) $42.190.325 106.214 0,13% Azioni
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $42.127.167 106.055 0,12% Azioni
AVIVA PLC $41.509.093 104.499 0,12% Azioni
VIRGINIA RETIREMENT SYSTEMS ET Al $41.468.472 161.904 0,12% Azioni
ROYAL BANK OF CANADA $41.033.000 103.301 0,12% Azioni
Pentwater Capital Management LP $39.722.000 100.000 0,12% Opzione Call
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $39.284.661 98.899 0,12% Azioni
Point72 Asset Management, L.P. $39.122.595 98.491 0,12% Azioni
PFM Health Sciences, LP $37.487.638 94.375 0,11% Azioni
Summit Street Capital Management, LLC $36.325.372 91.449 0,11% Azioni
Columbus Hill Capital Management, L.P. $35.501.935 89.376 0,11% Azioni
Korea Investment CORP $34.579.193 87.053 0,10% Azioni
Quantinno Capital Management LP $32.817.091 82.616 0,10% Azioni
Fisher Funds Management LTD $32.811.563 82.603 0,10% Azioni
Swedbank AB $32.034.603 80.647 0,10% Azioni

Insider aziendali 76 insider · 46 dirigenti · 27 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
James A. Rechtin President & CEO 14 Maggio 2025 P 30.474 0 0 $0
Bruce D Broussard Chief Executive Officer 21 Febbraio 2024 A 110.130 0 0 $0
Celeste Mellet Chief Financial Officer 24 Febbraio 2025 A 29.676 0 0 $0
Susan M Diamond Chief Financial Officer 31 Dicembre 2024 J 20.165 0 0 $0
Brian A Kane Chief Financial Officer 22 Febbraio 2021 A 24.342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer 09 Maggio 2014 G 14.916 0 0 $0
George Renaudin II President, Insurance 27 Marzo 2025 J 15.702 0 0 $0
David Dintenfass President, Enterprise Growth 24 Febbraio 2025 A 16.234 0 0 $0
Sanjay K Shetty President, CenterWell 24 Febbraio 2025 A 11.566 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions 24 Febbraio 2023 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail 15 Dicembre 2022 M 3.983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery 15 Dicembre 2017 M 222 0 0 $0
Thomas J Liston President - Retail Segment 18 Febbraio 2014 A 105.443 0 0 $0
James E Murray EVP & COO 31 Marzo 2017 J 34.668 0 0 $0
Japan Mehta Chief Information Officer 24 Febbraio 2025 A 8.628 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. 24 Febbraio 2025 A 1.767 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer 24 Febbraio 2025 A 11.266 0 0 $0
Joseph C Ventura Chief Legal Officer 24 Febbraio 2025 A 17.267 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer 24 Febbraio 2025 A 16.717 0 0 $0
Timothy S. Huval Chief Administrative Officer 31 Dicembre 2024 G 7.111 0 0 $0
Samir Deshpande Chief Information Officer 15 Dicembre 2024 M 14.015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer 21 Febbraio 2024 A 11.723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. 24 Febbraio 2023 F 3.687 0 0 $0
William H Shrank Chief Medical Officer 01 Maggio 2022 M 4.294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont 22 Marzo 2022 J 5.723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. 25 Febbraio 2022 F 6.014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. 16 Marzo 2021 G 8.168 0 0 $0
Elizabeth D Bierbower Strategic Advisor 18 Dicembre 2019 M 18.092 0 0 $0
Brian P. Leclaire Strategic Advisor 15 Dicembre 2019 M 6.339 0 0 $0
Jody L Bilney Chief Consumer Officer 25 Febbraio 2019 A 9.774 0 0 $0
Roy A Beveridge, Chief Medical Officer 19 Febbraio 2019 M 10.791 0 0 $0
Todoroff M Christopher Chief Legal Officer 15 Dicembre 2018 M 11.136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer 15 Dicembre 2018 M 6.476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer 17 Marzo 2017 M 4.361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin 18 Febbraio 2014 A 1.101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services 18 Febbraio 2014 A 15.946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer 24 Giugno 2013 M 19.347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off 24 Dicembre 2012 G 2.287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of 28 Aprile 2012 F 11.946 0 0 $0
GOODMAN BRUCE J Sr. VP 23 Febbraio 2012 A 23.280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. 04 Febbraio 2009 I 0 0 0 $0
Arthur P Hipwell Senior Vice President 27 Marzo 2008 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel 25 Febbraio 2008 F 13.836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer 31 Dicembre 2007 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary 23 Febbraio 2007 M 57.548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm 06 Gennaio 2005 M 0 0 0 $0
Kurt J Hilzinger Direttore 30 Giugno 2026 A 19.448 0 0 $0
Frank A Damelio Direttore 02 Gennaio 2026 A 20.634 0 0 $0
Karen Katz Direttore 31 Dicembre 2025 A 590 0 0 $0
David T Feinberg Direttore 30 Giugno 2025 A 441 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 1 partecipazione

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante Depositato Partecipazione Stato Scopo Deposito
David A. Jones ×2 depositi 12 Novembre 2003 Deposito iniziale SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 199 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
FXH · First Trust Exchange-Traded AlphaDE… 2,95% 109.132 NS 30 Aprile 2026 N-PORT
SMRI · EA Series Trust 2,54% 58.016 NS 30 Aprile 2026 N-PORT
TGLB · T. Rowe Price Exchange-Traded Funds… 2,26% 2.111 NS 30 Aprile 2026 N-PORT
SRHQ · Elevation Series Trust 1,63% 13.322 NS 30 Aprile 2026 N-PORT
CVAR · ETF Opportunities Trust 1,51% 2.473 NS 30 Aprile 2026 N-PORT
HWSM · HOTCHKIS & WILEY FUNDS /DE/ 1,23% 85 NS 30 Giugno 2026 N-PORT
EPMV · Harbor ETF Trust 1,20% 225 NS 30 Aprile 2026 N-PORT
ABCS · EA Series Trust 1,19% 441 NS 29 Maggio 2026 N-PORT
MFSV · MFS Active Exchange Traded Funds Tr… 1,14% 17.702 NS 31 Maggio 2026 N-PORT
NUMV · Nushares ETF Trust 0,96% 17.434 NS 30 Aprile 2026 N-PORT
FTA · First Trust Exchange-Traded AlphaDE… 0,95% 52.223 NS 30 Aprile 2026 N-PORT
ITAN · EA Series Trust 0,77% 2.259 NS 29 Maggio 2026 N-PORT
CGMM · Capital Group Equity ETF Trust I 0,72% 65.925 NS 31 Maggio 2026 N-PORT
AUSF · Global X Funds 0,70% 19.401 NS 31 Maggio 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0,63% 211 NS 31 Maggio 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0,59% 30.459 NS 30 Aprile 2026 N-PORT
RXL · ProShares Trust 0,53% 1.258 NS 31 Maggio 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0,47% 2.755 NS 30 Aprile 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,46% 55.439 NS 30 Aprile 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,45% 28.340 NS 30 Aprile 2026 N-PORT
DEUS · DBX ETF Trust 0,43% 3.849 NS 29 Maggio 2026 N-PORT
CURE · Direxion Shares ETF Trust 0,41% 2.404 NS 30 Aprile 2026 N-PORT
SPXD · DBX ETF Trust 0,37% 81 NS 31 Maggio 2026 N-PORT
QARP · DBX ETF Trust 0,36% 887 NS 29 Maggio 2026 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0,34% 4.484 NS 31 Maggio 2026 N-PORT
GMOV · GMO ETF Trust 0,34% 1.004 NS 31 Maggio 2026 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0,32% 265.500 NS 31 Maggio 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,29% 12.439 NS 31 Maggio 2026 N-PORT
PALC · Pacer Funds Trust 0,29% 2.779 NS 30 Aprile 2026 N-PORT
SPVU · Invesco Exchange-Traded Fund Trust … 0,28% 1.250 NS 31 Maggio 2026 N-PORT
BRCE · MFS Active Exchange Traded Funds Tr… 0,27% 299 NS 31 Maggio 2026 N-PORT
FFLC · FIDELITY COVINGTON TRUST 0,26% 12.272 NS 30 Aprile 2026 N-PORT
GSEW · Goldman Sachs ETF Trust 0,24% 14.039 NS 31 Maggio 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,21% 4.491 NS 31 Maggio 2026 N-PORT
FLCV · Federated Hermes ETF Trust 0,20% 634 NS 31 Maggio 2026 N-PORT
FLCC · Federated Hermes ETF Trust 0,18% 708 NS 31 Maggio 2026 N-PORT
ROUS · Lattice Strategies Trust 0,16% 3.879 NS 30 Aprile 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,15% 4.555 NS 30 Aprile 2026 N-PORT
HELO · J.P. Morgan Exchange-Traded Fund Tr… 0,15% 24.794 NS 30 Aprile 2026 N-PORT
CATH · Global X Funds 0,13% 6.791 NS 30 Aprile 2026 N-PORT
DFLV · Dimensional ETF Trust 0,13% 32.836 NS 30 Aprile 2026 N-PORT
SCHG · SCHWAB STRATEGIC TRUST 0,13% 256.808 NS 31 Maggio 2026 N-PORT
ACVF · ETF Opportunities Trust 0,13% 790 NS 30 Aprile 2026 N-PORT
OALC · Unified Series Trust 0,12% 945 NS 31 Maggio 2026 N-PORT
DFSU · Dimensional ETF Trust 0,12% 10.240 NS 30 Aprile 2026 N-PORT
GSLC · Goldman Sachs ETF Trust 0,11% 55.850 NS 31 Maggio 2026 N-PORT
GVUS · Goldman Sachs ETF Trust 0,11% 1.461 NS 31 Maggio 2026 N-PORT
USSG · DBX ETF Trust 0,11% 2.008 NS 29 Maggio 2026 N-PORT
VEGN · ETF Series Solutions 0,10% 675 NS 30 Aprile 2026 N-PORT
DFUV · Dimensional ETF Trust 0,09% 57.804 NS 30 Aprile 2026 N-PORT